tm logo
Trademark Search
ATRECA

View On IC.GC.CA

ATRECA
REGISTERED

on 05 Sep 2023

Last Applicant/ Owned by

ATRECA INC.

835 Industrial Road, Suite 400San Carlos, California 94070

US

Serial Number

1942441 filed on 24th Jan 2019

Registration Number

TMA1196278 registered on 05th Sep 2023

Registration expiry Date

05th Sep 2033

Correspondent Address

4500 BANKERS HALL EAST855 - 2ND STREET S.W.CALGARY

ALBERTA

CA

T2P4K7

ATRECA

Trademark usage description

biological assays consisting primarily of monoclonal antibodies, pre-made buffer concentrates, and chemical reagents for clinical use and scientific r Read More

Classification Information

Class [001]
Biological assays consisting primarily of monoclonal antibodies, pre-made buffer concentrates, and chemical reagents for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of antibodies for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use

Classification kind code

11

Class [005]
Biological assays for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; pharmaceutical preparations, namely biologics for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, namely, biologics and antibodies for the treatment of oncological disorders and conditions; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologic pharmaceutical preparations, namely, antibodies for use with diagnostic agents for the diagnosis of oncological diseases, disorders and conditions in humans; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease

Classification kind code

11

Mark Details

Serial Number

1942441

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 10th May 2023		Approved
Submitted for opposition 27
on 10th May 2023		Approval Notice Sent
Submitted for opposition 22
on 14th Feb 2022		Search Recorded
Submitted for opposition 20
on 14th Feb 2022		Examiner's First Report
Submitted for opposition 135
on 20th Oct 2021		Amendment to Application
Submitted for opposition 135
on 24th Sep 2020		Amendment to Application
Submitted for opposition 48
on 18th Dec 2019		Agent Changed
Submitted for opposition 31
on 29th Jan 2019		Formalized
Submitted for opposition 1
on 25th Jan 2019		Created
Submitted for opposition 30
on 24th Jan 2019		Filed